These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22331743)

  • 1. Synchronous presentation of breast cancer and hepatocellular carcinoma in a postmenopausal woman: dual action of aromatase inhibitor on breast and hepatic cancer cells?
    Dede DS; Altundag K
    J BUON; 2011; 16(4):782. PubMed ID: 22331743
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
    Kao YC; Okubo T; Sun XZ; Chen S
    Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
    Winer EP; Hudis C; Burstein HJ; Wolff AC; Pritchard KI; Ingle JN; Chlebowski RT; Gelber R; Edge SB; Gralow J; Cobleigh MA; Mamounas EP; Goldstein LJ; Whelan TJ; Powles TJ; Bryant J; Perkins C; Perotti J; Braun S; Langer AS; Browman GP; Somerfield MR
    J Clin Oncol; 2005 Jan; 23(3):619-29. PubMed ID: 15545664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous primary breast cancer and hepatocellular carcinoma in a male patient: a case report.
    Tian F; Cui X; Li L; Lu H; Rong W; Bi C; Wu J
    Int J Clin Exp Pathol; 2015; 8(9):11722-8. PubMed ID: 26617917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
    J Clin Oncol; 2005 Aug; 23(22):5178-87. PubMed ID: 15998905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of quadruple cancer composed of the breast, kidney, liver and uterus carcinomas].
    Haba Y; Masuda H; Sugenoya A; Senga O; Kobayashi S; Iida F; Kato M
    Nihon Geka Gakkai Zasshi; 1990 May; 91(5):649-51. PubMed ID: 2166900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitors in breast cancer.
    Hiscox S; Davies EL; Barrett-Lee P
    Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: optimal adjuvant endocrine therapy of postmenopausal breast cancer.
    Cunnick G; Mokbel K
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):197-8. PubMed ID: 16468468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard].
    Jonat W
    MMW Fortschr Med; 2006 Mar; 148(12):10. PubMed ID: 16625996
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on aromatase inhibitors in breast cancer.
    Gould RE; Garcia AA
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):41-6. PubMed ID: 16493259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.
    Mouridsen HT; Lønning P; Beckmann MW; Blackwell K; Doughty J; Gligorov J; Llombart-Cussac A; Robidoux A; Thürlimann B; Gnant M
    Expert Rev Anticancer Ther; 2010 Nov; 10(11):1825-36. PubMed ID: 20883112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors--extending the benefits of adjuvant therapy beyond tamoxifen.
    Smith IE
    Breast; 2004 Dec; 13 Suppl 1():S3-9. PubMed ID: 15585377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibitors for adjuvant treatment of postmenopausal breast cancer.
    Med Lett Drugs Ther; 2011 Jun; 53(1366):47-8. PubMed ID: 21659970
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrospective analysis of concurrent vs. sequential administration of radiotherapy and hormone therapy using aromatase inhibitor for hormone receptor-positive postmenopausal breast cancer.
    Ishitobi M; Komoike Y; Motomura K; Koyama H; Nishiyama K; Inaji H
    Anticancer Res; 2009 Nov; 29(11):4791-4. PubMed ID: 20032437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of chronic lymphocytic leukemia with aromatase inhibitor-letrozole?
    Paydas S
    Leuk Res; 2009 Apr; 33(4):566-7. PubMed ID: 18585780
    [No Abstract]   [Full Text] [Related]  

  • 16. Aromatase inhibitors in the treatment of early and advanced breast cancer.
    Joensuu H; Ejlertsen B; Lønning PE; Rutqvist LE
    Acta Oncol; 2005; 44(1):23-31. PubMed ID: 15848903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of synchronous hepatocellular and esophageal carcinoma: case report and review of literature.
    Pelloni A; Guerra A; Gertsch P
    Hepatogastroenterology; 2001; 48(39):684-6. PubMed ID: 11462903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of synchronous gastric and hepatocellular carcinoma successfully treated by TS-1 and hepatic arterial infusion chemotherapy (HAI) of low-dose CDDP].
    Terakura M; Ikawa S; Kubota D; Katsuragi K; Ohba K; I S; Matsuyama M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2121-3. PubMed ID: 16352941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of the new aromatase inhibitors in the treatment of breast cancer.
    Sulkes A
    Isr Med Assoc J; 2005 Apr; 7(4):257-61. PubMed ID: 15847208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.